elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28972234-C9679ECE-BC96-41A8-853A-97E25C6D2173
Q28972234-C9679ECE-BC96-41A8-853A-97E25C6D2173
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28972234-C9679ECE-BC96-41A8-853A-97E25C6D2173
Triple Reuptake Inhibitors: A Premise and Promise
P2860
Q28972234-C9679ECE-BC96-41A8-853A-97E25C6D2173
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28972234-C9679ECE-BC96-41A8-853A-97E25C6D2173
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
319ac7c07cd66db6838c393da5cf5e671d0986eb
P2860
The dual-action hypothesis: does pharmacology matter?